Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 219-110-7 | CAS number: 2362-14-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
SKIN
Not irritating, rabbit; OECD 404 and EPA OPPTS 870.2500
EYE
Not irritating, rabbit; OECD 405 and EPA OPPTS 870.2400
Key value for chemical safety assessment
Skin irritation / corrosion
Link to relevant study records
- Endpoint:
- skin irritation: in vitro / ex vivo
- Data waiving:
- study scientifically not necessary / other information available
- Justification for data waiving:
- the study does not need to be conducted because an acute toxicity study by the dermal route does not indicate skin irritation up to the relevant limit dose level (2 000 mg/kg body weight)
- an in vitro skin irritation study does not need to be conducted because adequate data from an in vivo skin irritation study are available
- Justification for type of information:
- JUSTIFICATION FOR DATA WAIVING
An in vitro skin corrosion / irritation study does not need to be conducted because data from an existing in vivo skin irritation study are available. Additionally, studies to address information requirements 8.1.1 and 8.1.2 are not required in accordance with column 2 of REACH Annex VII because an acute study by the dermal route does not indicate skin irritation up to the limit dose level (2000 mg/kg bw). - Endpoint:
- skin irritation: in vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 404 (Acute Dermal Irritation / Corrosion)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.2500 (Acute Dermal Irritation)
- Deviations:
- no
- GLP compliance:
- yes
- Species:
- rabbit
- Strain:
- New Zealand White
- Details on test animals or test system and environmental conditions:
- Details on test animals and environment: Two male and one female (nulliparous and non-pregnant) New Zealand White rabbits, at least 10 weeks of age, weighing 2.09 to 2.26 kg were obtained from the supplier. The animals were acclimated for at least five days and individually housed in suspended stainless-steel cages with hardwood chips for bedding. They were provided food and tap water ad libitum. Room temperature was 68 ± 5 °F and the relative humidity ranged between 30 - 70 %. Room lights were on a 12-hour light/dark cycle.
- Type of coverage:
- semiocclusive
- Preparation of test site:
- shaved
- Vehicle:
- unchanged (no vehicle)
- Controls:
- not required
- Amount / concentration applied:
- Approximately 0.5 gram of the test substance was applied to a small area of the skin (approximately 6 cm²).
- Duration of treatment / exposure:
- 4 hour exposure period
- Observation period:
- Test sites were observed for signs of erythema and oedema 1, 24, 48 and 72 hours after patch removal. Daily clinical observations included all toxicologic and pharmacologic signs.
- Number of animals:
- 3
- Details on study design:
- Approximately 24 hours prior to dosing, the application sites were prepared by clipping the skin of the trunk free of hair (not less than 10 % of the body surface was clear for the application of the test substance). Approximately 0.5 gram of the test substance was applied to a small area of the skin (approximately 6 cm²). The application site was covered with a gauze patch and secured with non-irritating tape. The test was conducted with 3 animals, each receiving one patch for an exposure period of 4 hours. Test sites were observed for signs of erythema and oedema 1, 24, 48 and 72 hours after patch removal. Daily clinical observations included all toxicologic and pharmacologic signs. Animals were weighed on Day 0 (prior to dose administration) and at the end of the observation period (Day 3). All animals were euthanised with an injectable barbiturate after body weight collection on Day 3 and discarded without further evaluation.
- Irritation parameter:
- overall irritation score
- Basis:
- mean
- Time point:
- 24/48/72 h
- Score:
- 0
- Reversibility:
- other: not applicable
- Remarks on result:
- no indication of irritation
- Irritation parameter:
- erythema score
- Basis:
- mean
- Time point:
- 24/48/72 h
- Score:
- 0
- Max. score:
- 4
- Remarks on result:
- no indication of irritation
- Irritation parameter:
- edema score
- Basis:
- mean
- Time point:
- 24/48/72 h
- Score:
- 0
- Max. score:
- 4
- Remarks on result:
- no indication of irritation
- Irritant / corrosive response data:
- No signs of erythema or edema were present at any of the test or control sites at any of the observation periods.
- Other effects:
- All animals gained weight over the course of the study. No overt signs of toxicity were evident in any of the animals during the course of the study.
- Interpretation of results:
- other: Not classified according to EU criteria
- Conclusions:
- Under the conditions of this study, DMBPC is considered to be a non-irritant.
- Executive summary:
The irritation potential of the test material was investigate din accordance with the standardised guidelines OECD 404 and EPA OPPTS 870.2500 under GLP conditions.
The shaved skin of three New Zealand White rabbits was exposed to the test material in a semi-occlusive fashion for 4 hours. Approximately 0.5 gram of the test substance was applied to a small area of the skin (approximately 6 cm²).
Test sites were observed for signs of erythema and oedema 1, 24, 48 and 72 hours after patch removal. Daily clinical observations included all toxicologic and pharmacologic signs.
Animals were weighed on Day 0 (prior to dose administration) and at the end of the observation period (Day 3). All animals were euthanised with an injectable barbiturate after body weight collection on Day 3 and discarded without further evaluation.
No signs of erythema or oedema were present at any of the test or control sites at any of the observation periods.
All animals gained weight over the course of the study. No overt signs of toxicity were evident in any of the animals during the course of the study.
Under the conditions of this study, DMBPC is considered to be a non-irritant.
Referenceopen allclose all
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Eye irritation
Link to relevant study records
- Endpoint:
- eye irritation: in vitro / ex vivo
- Data waiving:
- study scientifically not necessary / other information available
- Justification for data waiving:
- an in vitro eye irritation study does not need to be conducted because adequate data from an in vivo eye irritation study are available
- Endpoint:
- eye irritation: in vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 405 (Acute Eye Irritation / Corrosion)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.2400 (Acute Eye Irritation)
- Deviations:
- no
- GLP compliance:
- yes
- Species:
- rabbit
- Strain:
- New Zealand White
- Details on test animals or tissues and environmental conditions:
- Two male and two female (nulliparous and non-pregnant) New Zealand White rabbits, at least 10 weeks of age, weighing 2.12 to 2.24 kg were obtained from the supplier. The animals were acclimated for at least five days and individually housed in suspended stainless-steel cages with hardwood chips for bedding. They were provided food and tap water ad libitum. Room temperature was 68 ± 5 °F and the relative humidity ranged between 30 - 70 %. Room lights were on a 12-hour light/dark cycle.
- Vehicle:
- unchanged (no vehicle)
- Controls:
- not required
- Amount / concentration applied:
- 0.1 mL (~50 mg)
- Duration of treatment / exposure:
- The test substance was instilled into the left eye by gently pulling the lower lid away from the eye to form a cup into which the test substance was placed. The upper and lower lids were gently held together for approximately one second to prevent the loss of the test substance. The eyes of the test animals were not rinsed at any time following test substance application.
- Observation period (in vivo):
- The eyes were examined at 1, 24, 48 and 72 hours after treatment
- Number of animals or in vitro replicates:
- 4 (1 preliminary and 3 main test animals)
- Details on study design:
- Within the 24 hours prior to dosing, the eyes of the animals selected for the test were examined to ensure that the eyes were free of abnormality, damage and disease, scored according to the Grades for Ocular Lesions and scored by Fluorescein Staining (details provided below). An initial procedure using a 10 % dilution of the test substance was performed on one animal. No irritation of the treated eye was observed and the study proceeded with the dosing of 3 additional animals with the neat test substance.
The animals were dosed in the left eye at a volume of 0.1 mL (~50 mg). The test substance was instilled into the left eye by gently pulling the lower lid away from the eye to form a cup into which the test substance was placed. The upper and lower lids were gently held together for approximately one second to prevent the loss of the test substance. The eyes of the test animals were not rinsed at any time following test substance application. The right eye remained untreated and served as a control. The eyes were examined at 1, 24, 48 and 72 hours after treatment and scored according to the Grades for Ocular Lesions provided below. In addition, after recording the scores at 24 hours, the eyes were further examined with the aid of fluorescein to further characterise corneal opacity. Evaluation of the eyes was facilitated by the use of a hand-held slit lamp. Animals were observed daily for clinical signs of toxicity. Animals were weighed at study start (Day 0) and completion (Day 3). - Irritation parameter:
- conjunctivae score
- Basis:
- mean
- Remarks:
- of the three animals
- Time point:
- 24/48/72 h
- Score:
- 0
- Max. score:
- 20
- Remarks on result:
- other: total conjunctiva score = redness score + chemosis score x 2
- Irritation parameter:
- iris score
- Basis:
- mean
- Remarks:
- of the three animals
- Time point:
- 24/48/72 h
- Score:
- 0
- Max. score:
- 10
- Remarks on result:
- other: total iris score = iris score x 5
- Irritation parameter:
- cornea opacity score
- Basis:
- mean
- Remarks:
- of the three animals
- Time point:
- 24/48/72 h
- Score:
- 0
- Max. score:
- 80
- Remarks on result:
- other: total cornea score = opacity score + area score x 5
- Irritation parameter:
- chemosis score
- Basis:
- mean
- Remarks:
- of the three animals
- Time point:
- 24/48/72 h
- Score:
- 0
- Max. score:
- 4
- Irritation parameter:
- conjunctivae score
- Remarks:
- redness
- Basis:
- animal #1
- Time point:
- other: 1 hour
- Score:
- 1
- Max. score:
- 3
- Reversibility:
- fully reversible within: 24 hours
- Remarks on result:
- other: total conjunctiva score = 2 (redness + chemosis x 2)
- Irritation parameter:
- conjunctivae score
- Remarks:
- redness
- Basis:
- animal #2
- Time point:
- other: 1 hour
- Score:
- 1
- Max. score:
- 3
- Reversibility:
- fully reversible within: 24 hours
- Remarks on result:
- other: total conjunctiva score = 2 (redness + chemosis x 2)
- Irritation parameter:
- conjunctivae score
- Remarks:
- redness
- Basis:
- animal #3
- Time point:
- other: 1 hour
- Score:
- 1
- Max. score:
- 3
- Reversibility:
- fully reversible within: 24 hours
- Remarks on result:
- other: total conjunctiva score = 2 (redness + chemosis x 2)
- Irritant / corrosive response data:
- No corneal or iridial involvement was observed in the test eyes of any animal at any time point. All three animals demonstrated mild conjunctival redness at the 1-hour scoring interval which resolved by the 24-hour observation period. No fluorescein staining was present in the test eyes at any time point during the study.
- Other effects:
- All animals gained weight and no systemic signs of toxicity were observed during the course of the study. No irritation was observed in the control eyes at any scoring interval.
- Interpretation of results:
- other: Not classified according to EU criteria
- Conclusions:
- Under the conditions of this study, DMBPC is considered to be not irritating.
- Executive summary:
The irritation potential of the test material was investigate din accordance with the standardised guidelines OECD 405 and EPA OPPTS 870.2400 under GLP conditions.
Test substance (0.1 mL, ~50 mg) was instilled into the left eye of 3 New Zealand White rabbits. The eyes of the test animals were not rinsed at any time following test substance application. The right eye remained untreated and served as a control. The eyes were examined at 1, 24, 48 and 72 hours after treatment. Animals were observed daily for clinical signs of toxicity. Animals were weighed at study start (Day 0) and completion (Day 3).
No corneal or iridial involvement was observed in the test eyes of any animal at any time point. All three animals demonstrated mild conjunctival redness at the 1-hour scoring interval which resolved by the 24-hour observation period. No fluorescein staining was present in the test eyes at any time point during the study. All animals gained weight and no systemic signs of toxicity were observed. No irritation was observed in the control eyes at any scoring interval.
Under the conditions of this study, DMBPC is considered to be not irritating.
Referenceopen allclose all
Results
Summary of Results for the Treated (Left) Eyes | |||||||
Animal No. | Effects at 1 hour | ||||||
Cornea | Iris | Conjunctiva | Fluor Exam | ||||
O | A | V | R | C | IS | A | |
10611 | 0 | 0 | 0 | 1 | 0 | n/a | n/a |
10612 | 0 | 0 | 0 | 1 | 0 | n/a | n/a |
10613 | 0 | 0 | 0 | 1 | 0 | n/a | n/a |
Effects at 24 hours | |||||||
10611 | 0 | 0 | 0 | 0 | 0 | n/a | n/a |
10612 | 0 | 0 | 0 | 0 | 0 | n/a | n/a |
10613 | 0 | 0 | 0 | 0 | 0 | n/a | n/a |
Effects at 48 hours | |||||||
10611 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
10612 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
10613 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Effects at 72 hours | |||||||
10611 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
10612 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
10613 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
O: Opacity; A: Area Involved V: Iritis Value R: Redness; C: Chemosis; Fluor: Fluorescein; IS: Intensity of staining; A: Area Involved n/a: not applicable |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Respiratory irritation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Skin
The irritation potential of the test material was investigated in accordance with the standardised guidelines OECD 404 and EPA OPPTS 870.2500 under GLP conditions. The study was awarded a reliability score of 1 in accordance with the criteria set forth by Klimisch et al. (1997).
The shaved skin of three New Zealand White rabbits was exposed to the test material in a semi-occlusive fashion for 4 hours. Approximately 0.5 gram of the test substance was applied to a small area of the skin (approximately 6 cm²).
Test sites were observed for signs of erythema and oedema 1, 24, 48 and 72 hours after patch removal. Daily clinical observations included all toxicologic and pharmacologic signs.
Animals were weighed on Day 0 (prior to dose administration) and at the end of the observation period (Day 3). All animals were euthanised with an injectable barbiturate after body weight collection on Day 3 and discarded without further evaluation.
No signs of erythema or oedema were present at any of the test or control sites at any of the observation periods.
All animals gained weight over the course of the study. No overt signs of toxicity were evident in any of the animals during the course of the study.
Under the conditions of this study, DMBPC is considered to be a non-irritant.
Eye
The irritation potential of the test material was investigate din accordance with the standardised guidelines OECD 405 and EPA OPPTS 870.2400 under GLP conditions. The study was awarded a reliability score of 1 in accordance with the criteria set forth by Klimisch et al. (1997).
Test substance (0.1 mL, ~50 mg) was instilled into the left eye of 3 New Zealand White rabbits. The eyes of the test animals were not rinsed at any time following test substance application. The right eye remained untreated and served as a control. The eyes were examined at 1, 24, 48 and 72 hours after treatment. Animals were observed daily for clinical signs of toxicity. Animals were weighed at study start (Day 0) and completion (Day 3).
No corneal or iridial involvement was observed in the test eyes of any animal at any time point. All three animals demonstrated mild conjunctival redness at the 1-hour scoring interval which resolved by the 24-hour observation period. No fluorescein staining was present in the test eyes at any time point during the study. All animals gained weight and no systemic signs of toxicity were observed. No irritation was observed in the control eyes at any scoring interval.
Under the conditions of this study, DMBPC is considered to be not irritating.
Justification for classification or non-classification
In accordance with the criteria for classification as defined in Annex I, Regulation (EC) No 1272/2008, the substance does not require classification with respect to skin or eye irritation / corrosion.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.